Endocrinology

Obesity

More in Obesity

'A Watershed Moment': GLP-1 Drug Succeeds in Late-Stage MASH Trial

First positive phase III study for a GLP-1 agonist in chronic liver disease

Nov 20, 2024
AASLD over a photo of San Diego Convention Center in San Diego, CA.
Opinion
GLP-1 Use Prior to Surgery: Analyzing the Updated Guidance

Balancing aspiration risk with the consequences of medication discontinuation

Nov 20, 2024
A photo of an injection pen.
Metformin Use Linked to Fewer Asthma Attacks

Addition of GLP-1 drugs led to an even greater reduction

Nov 19, 2024
A photo of a glucose meter lying on a box of metformin tablets.
75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data?

News and commentary from the endocrinology world

Nov 19, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy

Most are eligible for weight management indication

Nov 18, 2024
AHA over a photo of McCormick Place Convention Center in Chicago, IL.
Tirzepatide Officially Puts GLP-1 Meds on the Map for Obesity-Related Heart Failure

SUMMIT trial able to show clinical benefit beyond quality-of-life improvement

Nov 16, 2024
AHA over a photo of McCormick Place Convention Center in Chicago, IL.
GLP-1 Drugs Could Help People With Alcohol Use Disorder

Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations

Nov 13, 2024
A photo of a man holding a semaglutide injection pen.
16% of Adults Have Diabetes; Compounded Semaglutide Deaths; Testosterone Tx Surge

News and commentary from the endocrinology world

Nov 12, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugs

Plus: oral semaglutide outcomes and incident hypertension in teens on GLP-1 drugs

Nov 11, 2024
ObesityWeek over a photo of Henry B. González Convention Center in San Antonio, TX.
FDA Adds New Warning to GLP-1 Drugs

Labels now caution about pulmonary aspiration risk

Nov 08, 2024
A close up photo of a needle of a semaglutide injection pen.
Patients With Obesity Shed Pounds With Drug-Free Capsule

Participants also had improved cardiometabolic measures with Epitomee device

Nov 08, 2024
ObesityWeek over a photo of Henry B. González Convention Center in San Antonio, TX.
Nurse's Death Tied to GLP-1 Drug; Research Monkey Jailbreak; Congressman Has Cancer

Health news and commentary gathered by staff

Nov 08, 2024
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years

Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist

Nov 07, 2024
ObesityWeek over a photo of Henry B. González Convention Center in San Antonio, TX.
Counter-Marketing Messages Reduced Intent to Drink Sugary Beverages

Messages about unethical industry practices came with less perceived weight stigma

Nov 06, 2024
ObesityWeek over a photo of Henry B. González Convention Center in San Antonio, TX.
More in Obesity

0.50 CME Credits
Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes

0.75 CME Credits
Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care

0.25 CME Credits
Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

0.50 CME Credits
Examining the Pathophysiology, Burden, and Evolving Treatment Landscape of Acromegaly

0.50 CME Credits
Enhancing Acromegaly Care Through Integration of the Latest Clinical Evidence and Patient-Centered Management

0.50 CME Credits
Cutting-Edge Treatment Approaches for Patients With T1D and Impaired Awareness of Hypoglycemia (IAH)

0.50 CME Credits
Breakthroughs in Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome Management: Key Findings From ACC 2024

1.00 CME Credits
Navigating Cardiovascular Risk: The Critical Role of Lipoprotein(a) Screening and Treatment